Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Immunotech Biopharm Ltd ( (HK:6978) ) is now available.
Immunotech Biopharm Ltd has announced a trading halt on its shares, effective from September 19, 2025, due to the pending release of an announcement regarding a rights issue. This development is significant as it involves inside information that could impact the company’s operations and stakeholder interests.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative immunotherapy products. The company operates in the healthcare industry with a market focus on cutting-edge biopharmaceutical advancements.
Average Trading Volume: 1,026,205
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.45B
Find detailed analytics on 6978 stock on TipRanks’ Stock Analysis page.